| Dr Jesus Trevino, MD, MBA | |
|
2120 L St Nw Ste 450, Washington, DC 20037-1541 | |
| (202) 741-2911 | |
| Not Available |
| Full Name | Dr Jesus Trevino |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 2120 L St Nw Ste 450, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053708016 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| George Washington Univ Hospital | Washington, DC | Hospital |
| United Medical Center | Washington, DC | Hospital |
| Hca Houston Healthcare West | Houston, TX | Hospital |
| Shannon Medical Center | San angelo, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
Doctors may be able to predict which girls are at risk of developing eating disorders based on the food choices they make when they are younger, according to a new study by Cincinnati Children's Hospital Medical Center.
The number of people being admitted to hospital for eating disorders in the UK has increased by more than one-third (37%) over the last two years.
Asbestos Disease Awareness Organization today announced it has awarded 20 volunteers with the PRESIDENTIAL VOLUNTEER SERVICE AWARD, a national honor offered in recognition of volunteer service.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 1 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
Doctors may be able to predict which girls are at risk of developing eating disorders based on the food choices they make when they are younger, according to a new study by Cincinnati Children's Hospital Medical Center.
The number of people being admitted to hospital for eating disorders in the UK has increased by more than one-third (37%) over the last two years.
Asbestos Disease Awareness Organization today announced it has awarded 20 volunteers with the PRESIDENTIAL VOLUNTEER SERVICE AWARD, a national honor offered in recognition of volunteer service.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jesus Trevino, MD, MBA 2120 L St Nw Ste 450, Washington, DC 20037-1541 Ph: (202) 741-2911 | Dr Jesus Trevino, MD, MBA 2120 L St Nw Ste 450, Washington, DC 20037-1541 Ph: (202) 741-2911 |
News Archive
Doctors may be able to predict which girls are at risk of developing eating disorders based on the food choices they make when they are younger, according to a new study by Cincinnati Children's Hospital Medical Center.
The number of people being admitted to hospital for eating disorders in the UK has increased by more than one-third (37%) over the last two years.
Asbestos Disease Awareness Organization today announced it has awarded 20 volunteers with the PRESIDENTIAL VOLUNTEER SERVICE AWARD, a national honor offered in recognition of volunteer service.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its selective histone deacetylase (HDAC) inhibitors will be featured in five posters and one oral presentation at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place December 8-11, 2012, in Atlanta, Georgia.
› Verified 1 days ago
Emily Jean Siegel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-8080 | |
Todd Templeman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 110 Irving St Nw, Suite Na-1177, Washington, DC 20010 Phone: 202-877-7632 Fax: 202-877-2468 | |
James A. D'orta, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Pennsylvania Ave Nw, Suite 550, Washington, DC 20006 Phone: 202-955-0000 | |
Guenevere Vanessa Burke, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-741-3581 | |
Jennifer Yu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, C/o Surgical Critical Care Services, Washington, DC 20010 Phone: 202-877-7000 | |
Diane A Sauter, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-2119 | |
Namman N Halabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 |